Novel application of icariin to resisting of oxygen deficiency
An icariin and anti-hypoxia technology, which is applied in the directions of antitoxins, medical preparations containing active ingredients, organic active ingredients, etc. Problems such as high doses
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Example 1: Protective effect of icariin on hypoxia-induced vascular endothelial cell injury
[0029] 1. Experimental materials and methods
[0030] 1. Materials The human umbilical cord endothelial cell line ECV-304 was obtained from the American Tissue Culture Bank (ATCC CRI-1998). Icariin was provided by Peking University Shijia Research Center. DMEM medium, trypsin, and tetramethylazolazolium blue (MTT) were purchased from GIBCO, USA. Fetal bovine serum was a product of Tianjin Zhengjiang High-tech Co., Ltd. Dimethyl sulfoxide (DMSO) was purchased from Amresco. RNase and PI are products of Sigma Company. The cultured cell fluorescence staining apoptosis display kit is a product of Beijing Weiglass Co., Ltd. Hypoxic device system for French BioMé company's product. Microplate reader (Multiskan MK3) was purchased from Shanghai Leibo Analytical Instrument Co., Ltd. The UV-Vis spectrophotometer (UV-2501PC) is a product of Shimadzu Corporation, Japan. The flow c...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com